July 2, 2011

Barry Marshall   - Nobel Prize winner in medicine has developed a vaccine against Flu Whose delivery into the human body deals with bacteria Helicobacter pylori Have adapted to survive in the stomach. The following year, the United States will host the first stage of clinical trials, which will be attended by over 30 people, according to the agency Bloomberg.

Varieties Helicobacter That live in the gastrointestinal tract of humans and do not lead to development peptic ulcer It proposed to use in a new vaccine. Marshall proposed in the genome of bacteria contribute genes that encode certain proteins in the surface of influenza virus. In a human body, formed of an immune response that is directed against the virus.

After spending last year in Australia, a preliminary study, Marshall proved that the use of H. pylori does not cause damage to health. Bacterium getting any participants in the experiment, along with meat broth. Preparations on the basis of this bacterium in the future it is planned to produce in the form of capsules and powders.

The development of a new vaccine is engaged in a private clinic Marshall. As Marshall says, the company has given the attractiveness of the project to potential investors, decided to start with the development of a vaccine against influenza. Theoretically, the same technology can be used to create vaccines against a variety of other infections and in the same manner in the human body can deliver various medications.

Barry Marshall   and Robin Warren   in 2005, it was deemed worthy of the Nobel Prize for Medicine and Physiology, opened the bacterium Helicobacter and describe the role of bacteria in the human body in the development of gastric ulcers and duodenal ulcers.